Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nucleus Tractus Solitarius (NTS) is a major sensory integration hub located in the dorsal medulla of the brainstem. It serves as the primary recipient of visceral afferent information from the facial (VII), glossopharyngeal (IX), and vagus (X) nerves, processing signals related to blood pressure, blood gases, gastrointestinal distension, and taste [5, 7, 8]. The NTS is essential for the coordination of autonomic reflexes, including the baroreflex and chemoreflex, which maintain cardiovascular and respiratory stability [1, 8]. Additionally, it plays a pivotal role in metabolic homeostasis by integrating peripheral satiety signals like GLP-1 and leptin to regulate food intake [2, 13]. While the NTS is an anatomical structure rather than a single molecule, it contains a high density of therapeutic targets such as GLP-1 receptors and alpha-2 adrenergic receptors, making it a key site of action for drugs treating obesity, diabetes, and hypertension [2, 9]. Dysfunction within NTS circuits is linked to various pathologies, including neurogenic hypertension, heart failure, and eating disorders [1, 8].
The Nucleus Tractus Solitarius (NTS) integrates visceral sensory signals and modulates autonomic output through the activation of specific receptors (e.g., GLP-1R, alpha-2 adrenergic, and D2 receptors) on its constituent neurons, thereby regulating reflexes and metabolic homeostasis [2, 7, 9].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleus tractus solitarius (NTS).